BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28118176)

  • 21. The impacts of an inflammatory bowel disease nurse specialist on the quality of care and costs in Finland.
    Molander P; Jussila A; Toivonen T; Mäkkeli P; Alho A; Kolho KL
    Scand J Gastroenterol; 2018 Dec; 53(12):1463-1468. PubMed ID: 30600722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased arterial stiffness in inflammatory bowel diseases is dependent upon inflammation and reduced by immunomodulatory drugs.
    Zanoli L; Rastelli S; Inserra G; Lentini P; Valvo E; Calcagno E; Boutouyrie P; Laurent S; Castellino P
    Atherosclerosis; 2014 Jun; 234(2):346-51. PubMed ID: 24732573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The multidisciplinary team for management of inflammatory bowel diseases.
    Ricci C; Lanzarotto F; Lanzini A
    Dig Liver Dis; 2008 Jul; 40 Suppl 2():S285-8. PubMed ID: 18599002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Burden of disease and increasing prevalence of inflammatory bowel disease in a population-based cohort in the Netherlands.
    de Groof EJ; Rossen NG; van Rhijn BD; Karregat EP; Boonstra K; Hageman I; Bennebroek Evertsz F; Kingma PJ; Naber AH; van den Brande JH; Mallant-Hent RC; Mundt MW; D'Haens GR; Ponsioen CY
    Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):1065-72. PubMed ID: 27281507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health Care Cost for Children Newly Diagnosed With Inflammatory Bowel Disease.
    Fondell AW; Mosha MH; Frank CR; Brangi JM; Hyams JS
    Inflamm Bowel Dis; 2020 Mar; 26(4):635-640. PubMed ID: 31504513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delphi consensus statement: Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units.
    Calvet X; Panés J; Alfaro N; Hinojosa J; Sicilia B; Gallego M; Pérez I; Lázaro y de Mercado P; Gomollón F; ; Aldeguera X; Alós R; Andreu M; Barreiro M; Bermejo F; Casis B; Domenech E; Espín E; Esteve M; García-Sánchez V; López-Sanromán A; Martínez-Montiel P; Luis Mendoza J; Gisbert JP; Vera M; Dosal A; Sánchez E; Marín L; Sanromán L; Pinilla P; Murciano F; Torrejón A; Ramón García J; Ortega M; Roldán J
    J Crohns Colitis; 2014 Mar; 8(3):240-51. PubMed ID: 24295646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
    Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
    Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The financial impact of a nurse-led telemedicine service for inflammatory bowel disease in a large district general hospital.
    Squires SI; Boal AJ; Naismith GD
    Frontline Gastroenterol; 2016 Jul; 7(3):216-221. PubMed ID: 28839858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Costs of ambulant care for patients with inflammatory bowel disease in general practice].
    Beiche A; König HH; Ebinger M; Matysiak-Klose D; Braun V; Leidl R
    Z Gastroenterol; 2003 Jun; 41(6):527-36. PubMed ID: 12806538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psoriasiform Skin Lesions Are Caused by Anti-TNF Agents Used for the Treatment of Inflammatory Bowel Disease.
    George LA; Gadani A; Cross RK; Jambaulikar G; Ghazi LJ
    Dig Dis Sci; 2015 Nov; 60(11):3424-30. PubMed ID: 26115749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low risk of Clostridium difficile infections in hospitalized patients with inflammatory bowel disease in a German tertiary referral center.
    Ott C; Girlich C; Klebl F; Plentz A; Iesalnieks I; Schölmerich J; Obermeier F
    Digestion; 2011; 84(3):187-92. PubMed ID: 21646782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of the prevalence and characteristics of anemia in inflammatory bowel diseases between 1993 and 2003.
    Vijverman A; Piront P; Belaiche J; Louis E
    Acta Gastroenterol Belg; 2006; 69(1):1-4. PubMed ID: 16673554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical management of inflammatory bowel disease in the new millennium.
    Lombardi DA; Feller ER; Shah SA
    Compr Ther; 2002; 28(1):39-49. PubMed ID: 11894442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005.
    Herrinton LJ; Liu L; Fireman B; Lewis JD; Allison JE; Flowers N; Hutfless S; Velayos FS; Abramson O; Altschuler A; Perry GS
    Gastroenterology; 2009 Aug; 137(2):502-11. PubMed ID: 19445944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory Bowel Disease Nurse-Practical Messages.
    Rosso C; Aaron AA; Armandi A; Caviglia GP; Vernero M; Saracco GM; Astegiano M; Bugianesi E; Ribaldone DG
    Nurs Rep; 2021 Apr; 11(2):229-241. PubMed ID: 34968201
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term effectiveness of azathioprine in IBD beyond 4 years: a European multicenter study in 1176 patients.
    Holtmann MH; Krummenauer F; Claas C; Kremeyer K; Lorenz D; Rainer O; Vogel I; Böcker U; Böhm S; Büning C; Duchmann R; Gerken G; Herfarth H; Lügering N; Kruis W; Reinshagen M; Schmidt J; Stallmach A; Stein J; Sturm A; Galle PR; Hommes DW; D'Haens G; Rutgeerts P; Neurath MF
    Dig Dis Sci; 2006 Sep; 51(9):1516-24. PubMed ID: 16927148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cost of general medical care of patients suffering from chronic inflammatory bowel disease].
    Bokemeyer B
    Z Gastroenterol; 2003 Sep; 41(9):963-4. PubMed ID: 13130334
    [No Abstract]   [Full Text] [Related]  

  • 39. Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options.
    Franceschet I; Cazzagon N; Del Ross T; D'Incà R; Buja A; Floreani A
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):508-13. PubMed ID: 26872110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease.
    Sack C; Phan VA; Grafton R; Holtmann G; van Langenberg DR; Brett K; Clark M; Andrews JM
    J Crohns Colitis; 2012 Apr; 6(3):302-10. PubMed ID: 22405166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.